Description
55,800 equity shares of Trident Lifeline Limited listed on BSE with effect from January 9, 2026, issued at Rs. 266 per share on preferential basis pursuant to warrant conversion, with lock-in until July 14, 2027.
Summary
BSE has approved the listing of 55,800 new equity shares of Trident Lifeline Limited (Scrip Code: 543616) with effect from January 9, 2026. These shares were issued at a premium of Rs. 256 per share (face value Rs. 10) to promoters and non-promoters on a preferential basis pursuant to conversion of warrants. The shares are subject to lock-in until July 14, 2027.
Key Points
- 55,800 equity shares of Rs. 10 face value each listed
- Issue price: Rs. 266 per share (Rs. 256 premium)
- Issued to promoters and non-promoters on preferential basis
- Allotment pursuant to conversion of warrants
- Distinguished Numbers: 11642001 to 11697800
- ISIN: INE0MKA01014
- Shares rank pari-passu with existing equity shares
- Trading commences: January 9, 2026
Regulatory Changes
No regulatory changes introduced. Standard listing procedure for preferential allotment completed.
Compliance Requirements
- Trading members should note the new securities in their systems
- All 55,800 shares are subject to mandatory lock-in provisions
- Lock-in restrictions must be enforced at depository level
Important Dates
- Date of Allotment: December 5, 2025
- Trading Commencement Date: January 9, 2026
- Lock-in Period Ends: July 14, 2027
Impact Assessment
Market Impact: Minimal. The preferential allotment represents a small number of shares relative to typical equity base. The shares carry standard lock-in restrictions preventing immediate sale, limiting near-term supply impact.
Liquidity Impact: Neutral to slightly positive in the long term once lock-in expires. No immediate trading impact expected.
Price Impact: Negligible. Small allotment size and lock-in provisions minimize dilution concerns.
Impact Justification
Routine preferential allotment representing small dilution (55,800 shares) with standard lock-in provisions; limited market impact expected.